Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
In published preclinical work, KPV has been studied for inhibiting NF-B activation in intestinal epithelial cells, with one widely cited study showing PepT1-mediated transport into colonic cells as part of its anti-inflammatory mechanism in mouse colitis models (Dalmasso et al., Gastroenterology , 2008)
Treatment adoption is growing by 38%, supported by healthcare investments in nearly 44% of countries
Reactions persisting beyond 34 days warrant medical review
Flumazenil, naloxone and the coma cocktail
US$ 29.57
US$ 21.19
US$ 28.94
